223 related articles for article (PubMed ID: 24928215)
21. Evaluation of greater wax moth larvae, Galleria mellonella, as a novel in vivo model for non-tuberculosis Mycobacteria infections and antibiotic treatments.
Entwistle FM; Coote PJ
J Med Microbiol; 2018 Apr; 67(4):585-597. PubMed ID: 29458557
[TBL] [Abstract][Full Text] [Related]
22. Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model.
Yang H; Chen G; Hu L; Liu Y; Cheng J; Ye Y; Li J
J Microbiol Immunol Infect; 2018 Feb; 51(1):70-75. PubMed ID: 26906264
[TBL] [Abstract][Full Text] [Related]
23. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.
Oie S; Uematsu T; Sawa A; Mizuno H; Tomita M; Ishida S; Okano Y; Kamiya A
J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851
[TBL] [Abstract][Full Text] [Related]
24. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Hu YF; Liu CP; Wang NY; Shih SC
BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
[TBL] [Abstract][Full Text] [Related]
25. Fish oils against Burkholderia and Pseudomonas aeruginosa: in vitro efficacy and their therapeutic and prophylactic effects on infected Galleria mellonella larvae.
Mil-Homens D; Ferreira-Dias S; Fialho AM
J Appl Microbiol; 2016 Jun; 120(6):1509-19. PubMed ID: 27012860
[TBL] [Abstract][Full Text] [Related]
26. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
[TBL] [Abstract][Full Text] [Related]
27. Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model.
Wang L; Tkhilaishvili T; Bernal Andres B; Trampuz A; Gonzalez Moreno M
Int J Antimicrob Agents; 2020 Dec; 56(6):106200. PubMed ID: 33075514
[TBL] [Abstract][Full Text] [Related]
28. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
Chan E; Zhou S; Srikumar S; Duan W
Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
[TBL] [Abstract][Full Text] [Related]
29. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
Yasmin F; Akhtar N; Hameed A
Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
[TBL] [Abstract][Full Text] [Related]
30. In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
Oie S; Sawa A; Kamiya A; Mizuno H
J Antimicrob Chemother; 1999 Nov; 44(5):689-91. PubMed ID: 10552987
[TBL] [Abstract][Full Text] [Related]
31. Carbapenem-Only Combination Therapy against Multi-Drug Resistant
Mackay B; Parcell BJ; Shirran SL; Coote PJ
Antibiotics (Basel); 2022 Oct; 11(11):. PubMed ID: 36358122
[TBL] [Abstract][Full Text] [Related]
32. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
Yang H; Lv N; Hu L; Liu Y; Cheng J; Ye Y; Li J
Infect Dis (Lond); 2016; 48(3):189-94. PubMed ID: 26503239
[TBL] [Abstract][Full Text] [Related]
33. Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment.
Meir M; Grosfeld T; Barkan D
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437630
[TBL] [Abstract][Full Text] [Related]
34. Species-specific activity of antibacterial drug combinations.
Brochado AR; Telzerow A; Bobonis J; Banzhaf M; Mateus A; Selkrig J; Huth E; Bassler S; Zamarreño Beas J; Zietek M; Ng N; Foerster S; Ezraty B; Py B; Barras F; Savitski MM; Bork P; Göttig S; Typas A
Nature; 2018 Jul; 559(7713):259-263. PubMed ID: 29973719
[TBL] [Abstract][Full Text] [Related]
35. [In vitro combined effects of double antibacterial drugs against multidrug-resistant Pseudomonas aeruginosa isolates: comparison among combinations of colistin, arbekacin, aztreonam, rifampicin and piperacillin].
Nagaoka R; Ikawa K; Onodera M; Koba Y; Hara T; Joichi Y; Yokozaki M; Ohge H; Morikawa N
Jpn J Antibiot; 2014 Jun; 67(3):167-74. PubMed ID: 25163250
[TBL] [Abstract][Full Text] [Related]
36. In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
Khalil MAF; Moawad SS; Hefzy EM
J Med Microbiol; 2019 Jan; 68(1):52-59. PubMed ID: 30422109
[TBL] [Abstract][Full Text] [Related]
37. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments.
Olsson A; Wistrand-Yuen P; Nielsen EI; Friberg LE; Sandegren L; Lagerbäck P; Tängdén T
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179531
[TBL] [Abstract][Full Text] [Related]
39. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial effects of drugs against multidrug-resistant Pseudomonas aeruginosa.
Maeda K; Kobayashi Y; Oie S; Ishida S; Okano Y; Kobayashi T; Shikichi K; Mizuno H; Kamiya A
Biol Pharm Bull; 2008 Oct; 31(10):1898-901. PubMed ID: 18827351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
